Stocks and Investing Stocks and Investing
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
Matthew Bouley Maintained (BLDR) at Buy with Increased Target to $107 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Kurt Yinger Maintained (BLDR) at Hold with Increased Target to $80 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Reuben Garner Maintained (BLDR) at Strong Buy with Increased Target to $115 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
David Manthey Maintained (BLDR) at Buy with Increased Target to $96 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Mike Dahl Maintained (BLDR) at Hold with Increased Target to $78 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Darko Mihelic Maintained (BNS) at Hold with Decreased Target to $77 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Sameer Joshi Reiterated (BLNK) at Strong Buy and Held Target at $50 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $55 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (ZM) at Strong Sell with Increased Target to $68 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Dan Leonard Maintained (A) at Buy with Increased Target to $170 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Catherine Schulte Maintained (A) at Buy with Increased Target to $174 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Derik De Bruin Maintained (A) at Strong Buy and Held Target at $164 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Puneet Souda Maintained (A) at Buy and Held Target at $170 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (ZVIA) at Buy with Decreased Target to $5 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Bobby Griffin Maintained (AAP) at Strong Buy with Decreased Target to $180 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Steven Zaccone Maintained (AAP) at Hold with Decreased Target to $153 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AAP) at Hold with Decreased Target to $155 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Michael Baker Maintained (AAP) at Hold with Decreased Target to $142 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Scot Ciccarelli Maintained (AAP) at Hold with Decreased Target to $144 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Joseph Bonner Maintained (ADSK) at Strong Buy with Decreased Target to $265 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Nathan Rich Maintained (XRAY) at Hold with Increased Target to $39 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Gaurav Mehta Reiterated (WSR) at Strong Buy and Held Target at $13 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Tim Moore Reiterated (XPEL) at Strong Buy and Held Target at $104 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Heather Balsky Maintained (VRSK) at Sell and Held Target at $167 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Noah Kaye Upgraded (VTNR) to Buy and Held Target at $14 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Amit Dayal Reiterated (VTNR) at Strong Buy and Held Target at $15 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (WRBY) at Buy with Decreased Target to $19 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Paul Lejuez Downgraded (WRBY) to Hold and Decreased Target to $13 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Mark Altschwager Maintained (WRBY) at Buy with Decreased Target to $20 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Vamil Divan Initiated (ANIP) at Strong Buy and Held Target at $55 on, Mar 1st, 2023

Vamil Divan Initiated (ANIP) at Strong Buy and Held Target at $55 on, Mar 1st, 2023


Published on 2024-10-28 02:01:33 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Guggenheim, Initiated "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy and Held Target at $55 on, Mar 1st, 2023.

Vamil has made no other calls on ANIP in the last 4 months.



There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Vamil's Rating of Hold.



This is the rating of the analyst that currently disagrees with Vamil

  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Tuesday, February 21st, 2023
Contributing Sources